Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AM03022PU-N - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#AM03022PU-N, RRID:AB_1622329
- Product name
- anti CD138 / Syndecan-1
- Antibody type
- Monoclonal
- Antigen
- U266 Human peripheral blood myeloma cell line
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- B-A38
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml
Submitted references The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.
Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.
Yang Y, MacLeod V, Dai Y, Khotskaya-Sample Y, Shriver Z, Venkataraman G, Sasisekharan R, Naggi A, Torri G, Casu B, Vlodavsky I, Suva LJ, Epstein J, Yaccoby S, Shaughnessy JD Jr, Barlogie B, Sanderson RD
Blood 2007 Sep 15;110(6):2041-8
Blood 2007 Sep 15;110(6):2041-8
G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.
Cheriyath V, Glaser KB, Waring JF, Baz R, Hussein MA, Borden EC
The Journal of clinical investigation 2007 Oct;117(10):3107-17
The Journal of clinical investigation 2007 Oct;117(10):3107-17
Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.
Kuchen S, Robbins R, Sims GP, Sheng C, Phillips TM, Lipsky PE, Ettinger R
Journal of immunology (Baltimore, Md. : 1950) 2007 Nov 1;179(9):5886-96
Journal of immunology (Baltimore, Md. : 1950) 2007 Nov 1;179(9):5886-96
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western Blot analysis using CD138 / Syndecan-1 Antibody Cat.-No AM03022PU-N (Clone B-A38) at 2 µg/ml in 1 mg/ml lysate, HeLa 10 µg (Lane 1+2), Raw 20µg (Lane 3+4) lysate, blocking buffer (Blotto; 5% dry milk powder in TBST). R1253HRP anti-Mouse IgG (H+L)-HRP as secondary antibody.